Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/16/2003 | CA2480084A1 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
10/16/2003 | CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components |
10/16/2003 | CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
10/15/2003 | EP1352903A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop |
10/15/2003 | EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases |
10/15/2003 | EP1352640A1 Compositions for retarding skin aging |
10/15/2003 | EP1352638A1 Cosmetics |
10/15/2003 | EP1352637A1 Hair growth inhibitors and compositions containing the same |
10/15/2003 | EP1352629A1 Use of a pyridine-dicarboxylic acid derivative or a salt thereof to stimulate or induce keratinic fiber growth and/or to prevent its loss |
10/15/2003 | EP1352627A2 Reduction of hair growth |
10/15/2003 | EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
10/15/2003 | EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
10/15/2003 | EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
10/15/2003 | EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
10/15/2003 | EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
10/15/2003 | EP1351953A1 Quinoline derivatives as nk-3 antagonists |
10/15/2003 | EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor |
10/15/2003 | EP1351933A1 Il-8 receptor antagonists |
10/15/2003 | EP1351929A1 Nitric oxide synthase inhibitor phosphate salt |
10/15/2003 | EP1351924A2 Diamines as modulators of chemokine receptor activity |
10/15/2003 | EP1351743A2 Liquid composition comprising an alcohol |
10/15/2003 | EP1351707A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
10/15/2003 | EP1351704A2 Storage stable powder compositions of interleukin-4 receptor |
10/15/2003 | EP1351702A1 Trem-1 splice variant for use in modifying immune responses |
10/15/2003 | EP1351697A2 Pharmaceutical for stimulating the regeneration of tissues |
10/15/2003 | EP1351694A1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
10/15/2003 | EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
10/15/2003 | EP1351663A1 Cosmetic and/or pharmaceutical preparations |
10/15/2003 | EP1351662A1 Cosmetic and/or pharmaceutical preparations |
10/15/2003 | EP1351647A1 Compositions and methods for treating hyperpigmentation |
10/15/2003 | EP1268471B1 N-heterocyclic derivatives as nos inhibitors |
10/15/2003 | EP1259508B1 Novel biarylcarboxamides |
10/15/2003 | EP1189627B1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
10/15/2003 | EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease |
10/15/2003 | EP1135103B1 Use of plant extracts with an anti-radical-type action and cosmetic or dermopharmaceutical composition comprising such extracts |
10/15/2003 | EP1001740B1 USE OF THE Rb 1 GINSENOSIDE FOR STIMULATING ELASTIN SYNTHESIS |
10/15/2003 | EP0910383B1 The use of growth factor modulating compounds |
10/15/2003 | EP0910367B1 Use of vitamin e acetate |
10/15/2003 | EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
10/15/2003 | EP0831769B1 Novel uses for thyroid hormones or thyroid hormone-like compounds |
10/15/2003 | CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
10/15/2003 | CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
10/15/2003 | CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
10/15/2003 | CN1449287A Fused pyrrolocarbazoles against inflammation |
10/15/2003 | CN1449284A 维生素c组合物 Vitamin c composition |
10/15/2003 | CN1449282A Treatment of burns |
10/15/2003 | CN1449274A Hair growers |
10/15/2003 | CN1449273A Antimicotic nail varnish composition |
10/15/2003 | CN1449271A Method and manufacture of a wound dressing for covering an open wound |
10/15/2003 | CN1448170A Chinese medicine for treating dermatopathy and gynecopathy disease and its preparing process |
10/15/2003 | CN1448168A Medicine for kidney reinforcing and beauty treatment |
10/15/2003 | CN1448161A Process formula of skin-care liquid |
10/15/2003 | CN1448160A Medicine for treating leukodermia and its preparing process |
10/15/2003 | CN1448155A Preparation for curing alopecia and its preparation method |
10/15/2003 | CN1448153A Ointment for treating dermatopathy and preparing process thereof |
10/15/2003 | CN1448152A Prep. of medicine for curing acne |
10/15/2003 | CN1448139A Antipruritic liniment |
10/15/2003 | CN1448137A Gatifloxacin external and ophthalmic gel preparation |
10/15/2003 | CN1124260C Para retinoic acid |
10/15/2003 | CN1124155C Medicine for treating leukoderma and preparing process |
10/15/2003 | CN1124147C Composite trichogen |
10/15/2003 | CN1124145C Chinese patent medicine for treating allergic dermatopathy |
10/14/2003 | US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
10/14/2003 | US6632962 Caspase inhibitors and uses thereof |
10/14/2003 | US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
10/14/2003 | US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor |
10/14/2003 | US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like |
10/14/2003 | US6632834 Compositions and methods for treating conditions responsive to estrogen |
10/14/2003 | US6632830 ACE-2 inhibiting compounds and methods of use thereof |
10/14/2003 | US6632798 Methods for inhibiting angiogenesis |
10/14/2003 | CA2367107C Methods for limiting scar and adhesion formation |
10/14/2003 | CA2109424C Anti-free-radical topical composition based on a superoxide-dismutase and a phosphonic derivative |
10/09/2003 | WO2003083114A1 Antiopoietin-related growth factor |
10/09/2003 | WO2003083092A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
10/09/2003 | WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
10/09/2003 | WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
10/09/2003 | WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy |
10/09/2003 | WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
10/09/2003 | WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
10/09/2003 | WO2003082867A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
10/09/2003 | WO2003082864A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them |
10/09/2003 | WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases |
10/09/2003 | WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives |
10/09/2003 | WO2003082853A1 New compounds |
10/09/2003 | WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
10/09/2003 | WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents |
10/09/2003 | WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators |
10/09/2003 | WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
10/09/2003 | WO2003082813A2 Improvements in pharmaceutical compositions |
10/09/2003 | WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein |
10/09/2003 | WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
10/09/2003 | WO2003082777A2 Novel glucocorticoid receptor ligands |
10/09/2003 | WO2003082372A2 Chemiluminescent treatment of acne |
10/09/2003 | WO2003082334A1 Drugs for increasing lacrimal fluid |
10/09/2003 | WO2003082326A1 Use of aprotinin for treating wounds and inflammation |
10/09/2003 | WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
10/09/2003 | WO2003082305A1 Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells |
10/09/2003 | WO2003082291A1 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions |